← Back to Clinical Trials
Recruiting NCT06179459

NCT06179459 Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06179459
Status Recruiting
Phase
Sponsor Orlando Health, Inc.
Condition Acute Pancreatitis
Study Type OBSERVATIONAL
Enrollment 110 participants
Start Date 2021-05-01
Primary Completion 2027-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Endoscopic management of pancreatic fluid collections

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 110 participants in total. It began in 2021-05-01 with a primary completion date of 2027-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Acute pancreatitis is one of the most common gastrointestinal disorders requiring hospitalization worldwide. Pancreatic fluid collections can occur as a consequence of acute and chronic pancreatitis and can result in significant morbidity and mortality, including significant abdominal pain, gastric outlet obstruction, biliary obstruction, organ failure, persistent unwellness, infection and sepsis. Symptomatic pancreatic fluid collections require treatment, and endoscopic drainage is considered standard of care. The aim of this study is to evaluate the treatment outcomes in patients undergoing standard of care, endoscopic treatment of pancreatic fluid collections.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years * All patients undergoing endoscopic treatment of pancreatic fluid collections Exclusion Criteria: * Age \< 18 years * Patients who did not receive endoscopic treatment of pancreatic fluid collections

Contact & Investigator

Central Contact

Ji Young Bang

✉ jiyoung.bang@orlandohealth.com

📞 321-841-2431

Principal Investigator

Ji Young Bang, MD MPH

PRINCIPAL INVESTIGATOR

Orlando Health, Digestive Health Institute

Frequently Asked Questions

Who can join the NCT06179459 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Pancreatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06179459 currently recruiting?

Yes, NCT06179459 is actively recruiting participants. Contact the research team at jiyoung.bang@orlandohealth.com for enrollment information.

Where is the NCT06179459 trial being conducted?

This trial is being conducted at Orlando, United States.

Who is sponsoring the NCT06179459 clinical trial?

NCT06179459 is sponsored by Orlando Health, Inc.. The principal investigator is Ji Young Bang, MD MPH at Orlando Health, Digestive Health Institute. The trial plans to enroll 110 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology